Peptide Atlas · Peptide
Goserelin
Goserelin is a GnRH agonist analogue that reduces testosterone secretion; in a randomized trial in 415 men with locally advanced prostate cancer, adding three years of goserelin to radiotherapy raised five-year survival from 62% to 79%.
- established
- provisional
- PubChem 5311128
- 2 citations
- 0 discussions
- 0 followers
- D-Ser(tBu)6-AzaGly10-LHRH
- Goserelin acetate
- Zoladex
What the evidence says
six tiers, never blendedestablished — replicated in humans, or settled by a regulator
every claim resolves to its source
All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.
Negative findings
failure is informationNobody has filed a failure yet. Failures are information; this list is waiting for an honest one.